Sumary of Study finds plasma from COVID-19 survivors doesn’t help seriously ill patients:
- ”“It has been thought that the blood plasma of COVID-19 survivors would help those seriously ill from the virus but, unfortunately, it does not,” said Donald Arnold, co-principal investigator of the study, hematologist and professor of medicine at McMaster University.
- ” Story continues below At the height of the pandemic, then-U.S. president Donald Trump gave emergency authorization to use convalescent plasma to treat COVID-19 patients, referring to it as “a breakthrough.
- ”Some researchers at the time believed using the antibody-rich plasma would provide benefits to those suffering the most severe effects of a coronavirus infection.
- 2:07 How COVID-19 survivors’ blood may help save lives Previous Video Next Video The statement came just days after the U.S. Food and Drug Administration (FDA) authorized “emergency use” of the treatment under its special powers amid a public health crisis.
- Story continues below A Canadian-led research team found that using convalescent plasma could actually increase the need for oxygen and worsen respiratory failure in a patient.
- It also found that the rate of fatal incidents was not any different from a group of patients who were not receiving the blood.
- An additional discovery in the research has also revealed that convalescent plasma had variable antibody content and even non-functional antibodies that are potentially harmful.